From: Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas
Left nonpolypoid adenomas | Right nonpolypoid adenomas | p-value | Left polypoid adenomas | Right polypoid adenomas | p-value | All adenomas left | All adenomas right | p-value | |
---|---|---|---|---|---|---|---|---|---|
SFRP2 | 79% (11/14) | 100% (29/29) | 0.3** | 93% (37/40) | 100% (4/4) | 1** | 89% (48/54) | 100% (33/33) | 0.08** |
WIF-1 | 69% (9/13) | 52% (15/29) | 0.3** | 86% (31/36) | 100% (3/3) | 1** | 82% (40/49) | 56% (18/32) | 0.013* |
DKK3 | 64% (9/14) | 82% (23/28) | 0.3** | 97% (35/36) | 100% (3/3) | 1** | 88% (44/50) | 84% (26/31) | 0.7** |
SOX17 | 86% (12/14) | 97% (28/29) | 0.2** | 100% (36/36) | 100% (3/3) | - | 96% (48/50) | 97% (31/32) | 1** |
All four combined | 38% (5/13) | 41% (11/27) | 0.9* | 78% (28/36) | 100% (3/3) | 1** | 67% (33/49) | 47% (14/30) | 0.07** |